Market Tracker

10/24 6:05pm ET

Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
13.15 -0.10 / -0.75%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.15 0.00 / 0.00%
 
Volume: 30.5K

Today’s Trading

Previous close13.25
Today’s open13.27
Day’s range12.93 - 13.58
Volume854,920
Average volume (3 months)1,302,051
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+53.84%
Earnings growth (next 5 years)+35.25%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co+1.00+2.01%
KERXKeryx Biopharmaceuti...+0.17+1.03%
DYAXDyax Corp+0.07+0.65%
ARIAARIAD Pharmaceutical...+0.12+2.10%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.39
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts